Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/24 16:10 | 11/6/24 | BEAM | Health | BioPrd | Biological Products, (No Diag | Ciaramella Giuseppe | MA | O | P | 3 | S.d | -2,773 | 19.26 | 0 | -144 | 160 | D | |||||||||||||||
10/2/24 17:52 | 10/1/24 | BEAM | Health | BioPrd | Biological Products, (No Diag | Bellon Christine | MA | O | GC | 1 | S | -9 | 23.48 | 0 | 0 | 0 | 104 | D | ||||||||||||||
10/2/24 17:51 | 10/1/24 | BEAM | Health | BioPrd | Biological Products, (No Diag | Cavanagh Bethany J | MA | O | SVP,Fina | 1 | S | -7 | 23.48 | 0 | 0 | 45 | D | |||||||||||||||
10/2/24 17:49 | 9/30/24 | BEAM | Health | BioPrd | Biological Products, (No Diag | Evans John M. | MA | DO | CEO | 1 | S | -1,476 | 24.60 | 0 | -60 | 1,042 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |